Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Lilly

Status and phase: Completed; Phase 2

Conditions: Carcinoma, Non Small Cell Lung

Treatments: Drug: Carboplatin; Drug: Gemcitabine; Drug: Paclitaxel

Study type: Interventional

Funder types: Industry

Identifiers

NCT00191256

B9E-US-S235

5488

Details and patient eligibility

About

To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically or cytologically confirmed non small cell lung cancer
• No prior chemotherapy or radiation for non small cell lung cancer
• No prior malignancy

Exclusion criteria

• Pregnancy or breastfeeding
• Serious concomitant disorders

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)